Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review

Código QR

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review

Warunya Woranush,1,2 Mats Leif Moskopp,2,3 Annahita Sedghi,1 Isabella Stuckart,1 Thomas Noll,2 Kristian Barlinn,1 Timo Siepmann1 1Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 2Institute of Physiology, Medical Faculty Carl Gustav Ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Woranush W, Moskopp ML, Sedghi A, Stuckart I, Noll T, Barlinn K, Siepmann T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	psd antidepressant depression prevention stroke Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/c4e0ae2a27de44c5bedcd2ef9296a340
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression
por: Liang ZH, et al.
Publicado: (2019)

Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis
por: Xiao J, et al.
Publicado: (2016)

Depressive-, Cognitive- or Stroke-Related Risk Factors of Post-Stroke Depression: Which One Could Better Help Clinicians and Patients?
por: Perrain R, et al.
Publicado: (2021)

A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
por: Chen C, et al.
Publicado: (2020)

Factors Affecting Post-Stroke Depression in Acute Ischemic Stroke Patients after 3 Months
por: Chan-Hyuk Lee, et al.
Publicado: (2021)

Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort
por: Lin S, et al.
Publicado: (2020)

Cerebrovascular Risk Profiles in a Saudi Arabian Cohort of Young Stroke Patients
por: Marwa Ahmed Eltemamy, et al.
Publicado: (2021)

Changes in brain arousal (EEG-vigilance) after therapeutic sleep deprivation in depressive patients and healthy controls
por: Christian Sander, et al.
Publicado: (2018)

Different molecular targets, one purpose – treatment of depression
por: Burat Magdalena, et al.
Publicado: (2020)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
por: Blat Diana, et al.
Publicado: (2021)

Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics
por: Hu Z, et al.
Publicado: (2019)

Construction of a Risk Model Associated with Prognosis of Post-Stroke Depression Based on Magnetic Resonance Spectroscopy
por: Qiao J, et al.
Publicado: (2020)

Preventive strategies for adolescent depression: What are we missing? A focus on biomarkers
por: Valentina Zonca
Publicado: (2021)

El diagnóstico diferencial entre la Depresión Bipolar y la Depresión Monopolar en la práctica clínica
por: LEYTON A,FANNY, et al.
Publicado: (2010)

Psicofarmacoterapia antidepresiva
por: Retamal C,Pedro
Publicado: (2001)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
por: Bhattacharjee S, et al.
Publicado: (2020)

Diabetes Care in Iran: Where We Stand and Where We Are Headed
por: Sina Noshad, et al.
Publicado: (2016)

Development and Validation of 3-Month Major Post-Stroke Depression Prediction Nomogram After Acute Ischemic Stroke Onset
por: Li G, et al.
Publicado: (2021)

The Combination of Insulin Resistance and Serum Interleukin-1β Correlates with Post-Stroke Depression in Patients with Acute Ischemic Stroke
por: Yi X, et al.
Publicado: (2021)

Urinary Metabolite Signatures for Predicting Elderly Stroke Survivors with Depression
por: Chen J, et al.
Publicado: (2021)

Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression
por: Gao J, et al.
Publicado: (2017)

Cognitive impairment in depression: recent advances and novel treatments
por: Perini G, et al.
Publicado: (2019)

New opinion on the subtypes of poststroke depression in Chinese stroke survivors
por: Yue Y, et al.
Publicado: (2017)

Diagnosis and Treatment of Depression in Patients with Schizophrenia
por: Sergey N. Mosolov
Publicado: (2020)

Monocyte-to-Lymphocyte Ratio is Associated with Depression 3 Months After Stroke
por: Ding K, et al.
Publicado: (2021)

The efficacy of traditional Thai massage in decreasing spasticity in elderly stroke patients
por: Thanakiatpinyo T, et al.
Publicado: (2014)

POST STROKE DEPRESSION: EXPERIENCE AT A TERTIARY CARE HOSPITAL OF PAKISTAN
por: Isbah Gul, et al.
Publicado: (2019)

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
por: Larisa Duffy, et al.
Publicado: (2021)

Where do we stand?
por: Ocampo, José Antonio
Publicado: (2014)

DYNAMICS OF FORMATION AND DEVELOPMENT OF DEPRESSIVE AND COGNITIVE DISORDERS IN PATIENTS AFTER CEREBRAL STROKE
por: V. B. Mikhaylov, et al.
Publicado: (2014)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
por: L. K. Khokhlov, et al.
Publicado: (2019)

¿Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
por: Silva,Hernán, et al.
Publicado: (2007)

Farmacoterapia de los trastornos depresivos unipolares en la mujer
por: Rees,Reginald
Publicado: (2002)

Participants’ Perspective of Engaging in a Gym-Based Health Service Delivered Secondary Stroke Prevention Program after TIA or Mild Stroke
por: Maria Sammut, et al.
Publicado: (2021)

DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
por: Waail Rozi, et al.
Publicado: (2021)

Serum lipid profiles and post-stroke depression in acute ischemic stroke patients
por: Shen H, et al.
Publicado: (2019)

Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
por: Erik Simon, et al.
Publicado: (2021)

Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics
por: Xie J, et al.
Publicado: (2020)

High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors
por: Liu ZH, et al.
Publicado: (2018)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
por: Michael Colla, et al.
Publicado: (2021)